These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 36352331)
21. CXCL17-derived CD11b Hsu YL; Yen MC; Chang WA; Tsai PH; Pan YC; Liao SH; Kuo PL Breast Cancer Res; 2019 Feb; 21(1):23. PubMed ID: 30755260 [TBL] [Abstract][Full Text] [Related]
22. Mucosal chemokine CXCL17: What is known and not known. Xiao S; Xie W; Zhou L Scand J Immunol; 2021 Feb; 93(2):e12965. PubMed ID: 32869346 [TBL] [Abstract][Full Text] [Related]
23. Advance in the role of chemokines/chemokine receptors in carcinogenesis: Focus on pancreatic cancer. Song N; Cui K; Zeng L; Li M; Fan Y; Shi P; Wang Z; Su W; Wang H Eur J Pharmacol; 2024 Mar; 967():176357. PubMed ID: 38309677 [TBL] [Abstract][Full Text] [Related]
24. CXCL17, an orphan chemokine, acts as a novel angiogenic and anti-inflammatory factor. Lee WY; Wang CJ; Lin TY; Hsiao CL; Luo CW Am J Physiol Endocrinol Metab; 2013 Jan; 304(1):E32-40. PubMed ID: 23115081 [TBL] [Abstract][Full Text] [Related]
25. CXCL17 expression by tumor cells recruits CD11b+Gr1 high F4/80- cells and promotes tumor progression. Matsui A; Yokoo H; Negishi Y; Endo-Takahashi Y; Chun NA; Kadouchi I; Suzuki R; Maruyama K; Aramaki Y; Semba K; Kobayashi E; Takahashi M; Murakami T PLoS One; 2012; 7(8):e44080. PubMed ID: 22952881 [TBL] [Abstract][Full Text] [Related]
26. Ectopic expression of the chemokine CXCL17 in colon cancer cells. Ohlsson L; Hammarström ML; Lindmark G; Hammarström S; Sitohy B Br J Cancer; 2016 Mar; 114(6):697-703. PubMed ID: 26889977 [TBL] [Abstract][Full Text] [Related]
27. CXCL17 binds efficaciously to glycosaminoglycans with the potential to modulate chemokine signaling. Giblin SP; Ranawana S; Hassibi S; Birchenough HL; Mincham KT; Snelgrove RJ; Tsuchiya T; Kanegasaki S; Dyer D; Pease JE Front Immunol; 2023; 14():1254697. PubMed ID: 37942327 [TBL] [Abstract][Full Text] [Related]
30. CXCL17-mediated downregulation of type I collagen via MMP1 and miR-29 in skin fibroblasts possibly contributes to the fibrosis in systemic sclerosis. Shimada S; Makino K; Jinnin M; Sawamura S; Kawano Y; Ide M; Kajihara I; Makino T; Fukushima S; Ihn H J Dermatol Sci; 2020 Dec; 100(3):183-191. PubMed ID: 33055012 [TBL] [Abstract][Full Text] [Related]
31. Exosomal DLX6-AS1 from hepatocellular carcinoma cells induces M2 macrophage polarization to promote migration and invasion in hepatocellular carcinoma through microRNA-15a-5p/CXCL17 axis. Wang LP; Lin J; Ma XQ; Xu DY; Shi CF; Wang W; Jiang XJ J Exp Clin Cancer Res; 2021 May; 40(1):177. PubMed ID: 34039401 [TBL] [Abstract][Full Text] [Related]
32. Endothelial YAP/TEAD1-CXCL17 signaling recruits myeloid-derived suppressor cells against liver ischemia-reperfusion injury. Zhang S; Sun Z; Chen Z; Bi Y; Wei S; Mao Z; Jin J; Ding Y; Wang W Hepatology; 2024 Feb; ():. PubMed ID: 38407233 [TBL] [Abstract][Full Text] [Related]
33. CXCL17 Is Dispensable during Hypervirulent Choreño-Parra JA; Dunlap MD; Swanson R; Jiménez-Álvarez LA; Muñoz-Torrico M; Guzmán-Beltrán S; Zúñiga J; Khader SA Immunohorizons; 2021 Sep; 5(9):752-759. PubMed ID: 34561226 [TBL] [Abstract][Full Text] [Related]
34. CXCL17 is a major chemotactic factor for lung macrophages. Burkhardt AM; Maravillas-Montero JL; Carnevale CD; Vilches-Cisneros N; Flores JP; Hevezi PA; Zlotnik A J Immunol; 2014 Aug; 193(3):1468-74. PubMed ID: 24973458 [TBL] [Abstract][Full Text] [Related]
35. CXCL17 expression predicts poor prognosis and correlates with adverse immune infiltration in hepatocellular carcinoma. Li L; Yan J; Xu J; Liu CQ; Zhen ZJ; Chen HW; Ji Y; Wu ZP; Hu JY; Zheng L; Lau WY PLoS One; 2014; 9(10):e110064. PubMed ID: 25303284 [TBL] [Abstract][Full Text] [Related]
36. Mechanism of lung adenocarcinoma spine metastasis induced by CXCL17. Liu W; Xie X; Wu J Cell Oncol (Dordr); 2020 Apr; 43(2):311-320. PubMed ID: 31832986 [TBL] [Abstract][Full Text] [Related]
37. Analysis of the mucosal chemokines CCL28, CXCL14, and CXCL17 in dry eye disease: An in vitro and clinical investigation. Domínguez-López A; Blanco-Vázquez M; Calderón-García AÁ; García-Vázquez C; González-García MJ; Calonge M; Enríquez-de-Salamanca A Exp Eye Res; 2024 Apr; 241():109854. PubMed ID: 38453037 [TBL] [Abstract][Full Text] [Related]
38. Intestinal guard: Human CXCL17 modulates protective response against mycotoxins and CXCL17-mimetic peptides development. Sun C; Shen H; Cai H; Zhao Z; Gan G; Feng S; Chu P; Zeng M; Deng J; Ming F; Ma M; Jia J; He R; Cao D; Chen Z; Li J; Zhang L Biochem Pharmacol; 2021 Jun; 188():114586. PubMed ID: 33932472 [TBL] [Abstract][Full Text] [Related]
39. Overexpression of CXCL17 increases migration and invasion of A549 lung adenocarcinoma cells. Koni E; Congur I; Tokcaer Keskin Z Front Pharmacol; 2024; 15():1306273. PubMed ID: 38384293 [TBL] [Abstract][Full Text] [Related]
40. The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors-A Review of Literature. Korbecki J; Kojder K; Kapczuk P; Kupnicka P; Gawrońska-Szklarz B; Gutowska I; Chlubek D; Baranowska-Bosiacka I Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467722 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]